The drug was approved by the US FDA in June 2021 as a 2.4 mg once-weekly injection for chronic weight management in adults with obesity or those overweight with at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol.3 In 2023, according to market information from Midas (IQVIA), sales of semaglutide for weight management more than quadrupled year-on-year, and further interest has been spurred by new indications related to reducing cardiovascular risk, and emerging benefits are being shown in people with Alzheimers disease.4,5 The strength of these figures clearly demonstrates the intense demand for GLP-1 treatments, but it does not convey the unforeseen implications of such high levels of popularity
Age Natural collagen production declines roughly 1% per year starting in your 20s
Elevated striatal -aminobutyric acid in youth with major depressive disorder
Follow-up consultations cost $40 and are required every six to nine months depending on your treatment protocol
5) Works in synergy with Glutathione
This article draws on dozens of candid conversations from women taking Wegovy